Stock TMDX TRANSMEDICS GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News TransMedics Group, Inc.

Equities

TMDX

US89377M1099

Real-time Estimate Cboe BZX
Other stock markets
 12:29:38 2024-06-05 pm EDT 		5-day change 1st Jan Change
137.2 USD +2.02% Intraday chart for TransMedics Group, Inc. -4.14% +72.82%
Jun. 04 Stephens Initiates TransMedics at Overweight Rating With $151 Price Target MT
Jun. 04 Stephens Starts TransMedics Group With Overweight Rating, $151 Price Target MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Stephens Initiates TransMedics at Overweight Rating With $151 Price Target
MT
Stephens Starts TransMedics Group With Overweight Rating, $151 Price Target
MT
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(4)
AQ
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
Transmedics Group Insider Sold Shares Worth $3,902,100, According to a Recent SEC Filing
MT
Transmedics Group Insider Sold Shares Worth $759,479, According to a Recent SEC Filing
MT
Transmedics Group Insider Sold Shares Worth $930,278, According to a Recent SEC Filing
MT
Transmedics Group Insider Sold Shares Worth $1,920,000, According to a Recent SEC Filing
MT
Transmedics Group Insider Sold Shares Worth $7,986,219, According to a Recent SEC Filing
MT
Transmedics Group Insider Sold Shares Worth $1,600,633, According to a Recent SEC Filing
MT
TransMedics Group Shares Rise as Q1 Swings to Net Income, Revenue Rises; Increases 2024 Revenue Outlook
MT
Oppenheimer Adjusts TransMedics Group Price Target to $125 From $105, Maintains Outperform Rating
MT
Earnings Flash (TMDX) TRANSMEDICS GROUP Posts Q1 Revenue $96.9M, vs. Street Est of $83.8M
MT
TransMedics Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : TransMedics Group, Inc., Q1 2024 Earnings Call, Apr 30, 2024
TransMedics: Q1 Earnings Snapshot
AQ
TransMedics Reports First Quarter 2024 Financial Results
PR
TransMedics Group, Inc. Raises Revenue Guidance for the Full Year 2024
CI
Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing
MT
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TMDX Stock
  4. News TransMedics Group, Inc.